<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27556324</article-id><article-id pub-id-type="pmc">5062718</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160030</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Dysfunctional Hyperpolarization-Activated Cyclic Nucleotide-gated Ion
Channels in Cardiac Diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Xiaoqi</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Tianxiang</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"/></contrib><aff id="aff1">Department of Cardiac Surgery ICU, The First Affiliated Hospital of
China Medical University, Shenyang, P.R. China</aff></contrib-group><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2016</year></pub-date><volume>31</volume><issue>2</issue><fpage>203</fpage><lpage>206</lpage><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are reverse
voltage-dependent, and their activation depends on the hyperpolarization of the
membrane and may be directly or indirectly regulated by the cyclic adenosine
monophosphate (cAMP) or other signal-transduction cascades. The distribution,
quantity and activation states of HCN channels differ in tissues throughout the
body. Evidence exhibits that HCN channels play critical roles in the generation
and conduction of the electrical impulse and the physiopathological process of
some cardiac diseases. They may constitute promising drug targets in the
treatment of these cardiac diseases. Pharmacological treatment targeting HCN
channels is of benefit to these cardiac conditions.</p></abstract><kwd-group><kwd>Ion Channel Gating</kwd><kwd>Cardiac Electrophysiology</kwd><kwd>Electrophysiological Processes.</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>The hyperpolarization-activated cyclic nucleotide-gated (HCN) channels comprise a
family of cation channels activated by hyperpolarized membrane potentials and
stimulated by intracellular cyclic nucleotides. The members of the family are four
human isoforms (HCN1-4). Upon hyperpolarization, all four isoforms generate a inward
current (If) in the heart and in the nervous system<sup>[<xref rid="r1" ref-type="bibr">1</xref>-<xref rid="r3" ref-type="bibr">3</xref>]</sup>. The
hyperpolarization-activated funny current (If) is a major determinant of cardiac
diastolic depolarization and plays a key role in controlling heart rate<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. The expression of HCN channel is
age-related, the expression has difference in distinct growth stages, HCN genes are
inactivated in ventricular myocytes cells following maturation whereas they
expressed in these cells in the fetal and/or neonatal heart<sup>[<xref rid="r5" ref-type="bibr">5</xref>-<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Three isoforms (HCN1, HCN2, HCN4) are expressed in cardiac
tissues, with HCN2 and HCN4 the dominant subtypes. In the healthy adult heart, HCN
channels are predominantly expressed in the conduction system, especially in the
sinoatrial node, HCN4 has been determined as the principal HCN isoform in sinoatrial
node cells. However, some studies demonstrate a significant expression of HCN1 and
also a small amount of HCN2 beneath HCN4 in murine sinoatrial cells at the protein
level, indicating that the three subunits together contribute to If in these
cells<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>. HCN2 has long been known to be expressed in
cardiac ventricular myocytes<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>,
and recently, the expression of HCN4 and low amounts of HCN1 and in addition a
functional role of HCN3 in ventricular myocytes has been demonstrated<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>]</sup>, but the expression of HCN channels in healthy adult
ventricular myocardium is generally weaker than in the conduction system, so If
currents are rarely detectable in normal ventricular myocytes<sup>[<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref>]</sup>. The kinetics of HCN1 is the fastest, followed by HCN2,
and the slowest is HCN4<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. cAMP
can make the potential of HCN channel open probability curve more positive. HCN2 and
HCN4 channels increased 10-20 mV, and HCN1 only 5 mV. HCN channel is also affected
by the endocrine system. Studies have demonstrated that HCN2 and HCN4 gene
transcription is controlled by thyroid hormone, so it is speculated that HCN2 and
HCN4 gene down-regulation level is an important mechanism for bradycardia induced by
hypothyroidism. Positive inotropic effect of thyroid hormone may be associated with
upregulation of the channel molecules<sup>[<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>]</sup>.</p></sec><sec><title>HCN AND CARDIOMYOPATHY</title><p>A large number of studies have found that in heart failure, atrial fibrillation,
myocardial hypertrophy and myocardial infarction, atrial and ventricular HCN2 and
HCN4 channels gene express unusually causing atrial or ventricular myocyte If
current rise or fall, and all of these may be associated with heart disease fatal
arrhythmia<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. Under
normal conditions, HCN channels are poorly expressed outside the cardiac pacemaking
and conduction system<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r18" ref-type="bibr">18</xref>-<xref rid="r20" ref-type="bibr">20</xref>]</sup>, but it changes during cardiac disease. During
hypertension and heart failure, If activity is observed in the ventricular
myocardium due to re-expression of HCN genes<sup>[<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r21" ref-type="bibr">21</xref>-<xref rid="r23" ref-type="bibr">23</xref>]</sup>, several studies proved that If current density
and occurrence is significantly greater in hypertrophic cardiomyocytes and end-stage
failing hearts and this is directly related to the arrhythmias<sup>[<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r24" ref-type="bibr">24</xref>-<xref rid="r27" ref-type="bibr">27</xref>]</sup>. Basing on the presence of If current in
ventricular myocytes isolated from severely hypertrophied rat hearts, the current
arrhythmogenic role in cardiac hypertrophy and failure has been inferred<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>, and its density is larger in
human ventricular myocytes isolated from the hearts of patients with ischemic than
in those with dilated cardiomyopathy<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. Stillitamo et al.<sup>[<xref rid="r27" ref-type="bibr">18</xref>]</sup> demonstrated for the first time comparing the mRNA and
protein expression of HCN subunits in the human atrial and ventricle under normal
and heart failure conditions in human heart failure, an upregulation of ventricular
HCN2 and HCN4 underlies the increase in functional If current, Michael et
al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>studied the model
with ventricular HCN2/4 knockout and identified the enhanced If as an important
contributor to the typical electrophysiological alterations observed in the
hypertrophic heart, including prolonged ventricular action potentials and lengthened
QT intervals. So the overexpression of If may contribute to increased ventricular
(and atrial) propensity to arrhythmias which leading to sudden death caused by
ventricular tachycardia or fibrillation in heart failure and hypertrophic heart.
Cardiac dysfunction is a complex and important problem for people with epilepsy.
Recently, a study has showed that cardiac electrophysiology was significantly
altered in adult rat models of genetic or acquired epilepsy, with slower heart rate,
shorter QRS duration, longer QTc interval, greater standard deviation of RR
intervals, and bradycardia, molecular analysis demonstrated significant reductions
in cardiac HCN2 mRNA and protein expression in models, providing a molecular
correlate of these electrophysiologic abnormalities<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>.</p></sec><sec><title>HCN AND ARRHYTHMIAS</title><p>HCN channels are essential for cardiac pacemaker and electric conduction. The cardiac
hyperpolarization activated cation current (If) is known to be present in region
with primary or second pacemaker activity, which is found in nonpacemaking regions
of the heart. In pacemaker regions, If is believed to contributed to spontaneous
diastolic depolarization. HCN1-knockout animals display a dysfunction of the
sinoatrial node resulting in sinus dysrhythmia, sinus pauses and a reduced cardiac
output, demonstrating that HCN1 contributes to a stable cardiac rhythm
generation<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>. Atrial
fibrillation is the most common sustained tachyarrhythmia and is one of the major
causes of cerebrovascular accident<sup>[<xref rid="r31" ref-type="bibr">31</xref>,<xref rid="r32" ref-type="bibr">32</xref>]</sup>. Clinical
electrophysiology studies in patients have demonstrated that rapid focal activity
originating from PV can trigger and maintain atrial fibrillation<sup>[<xref rid="r33" ref-type="bibr">33</xref>-<xref rid="r35" ref-type="bibr">35</xref>]</sup>. A study found that the pacing-induced spontaneous cation
potential and larger If current were observed in the PVs cardiac myocytes from
canine using RAP (rapid atrial pacing), and a slow diastolic depolarization in the
PVs cells. Meanwhile If current densities were significantly higher. As mentioned
above, delayed ventricular repolarization and prolonged QT intervals exist in
hypertrophic heart, and they can promote early afterdepolarizations and electrical
instability, so ventricular HCN channels may play a significant role in the diseased
heart by increasing the risk for severe ventricular arrhythmias<sup>[<xref rid="r36" ref-type="bibr">36</xref>,<xref rid="r37" ref-type="bibr">37</xref>]</sup>. For the patients with advanced atrioventricular block or
sick sinus syndrome, pacemakers are implanted. Biological pacemakers have several
advantages (improved cardiac output, no need for periodic resizing in a child during
maturation, among others), so the efforts to use gene therapy to create a biological
pacemaker have been ongoing for many years. And most of the efforts focused on HCN
gene family of channels. Plotnikov et al.<sup>[<xref rid="r38" ref-type="bibr">38</xref>]</sup> has proved that HCN212 chimeric channel is noteworthy,
therefore it resulted in tachycardia when overexpressed in the canine left bundle
branch to achieve the desired physiological range.</p></sec><sec><title>HCN CHANNEL BLOCKERS</title><p>It is well known that slow heart beat is good for the heart. Therefore, HCN channels
become the main target of the drug study controlling rapid arrhythmia. Recently,
there are many studies about ivabradine, the first selective blocker of If current.
A work done by Kuwabara et al.<sup>[<xref rid="r39" ref-type="bibr">39</xref>]</sup>
analyzed the effect of ivabradine on survival and rhythmicity in a transgenic mouse
model (dnNRSF) of dilated cardiomyophathy, and the founding is although an increased
cardiac expression of If accompanied by ventricular tachyarrhythmias and sudden
arrhythmic death, the survival was improved significantly when ivabradine was
administrated at low doses without affecting heart rate. Ivabradine can markedly
reduce If currents in the RAP (rapid atrial pacing) cells in a
concentration-dependence manner<sup>[<xref rid="r40" ref-type="bibr">40</xref>]</sup>. It has been proved that Ivabradine can reduce heart rate
without exerting negative inotropic or vasodilatory effects<sup>[<xref rid="r41" ref-type="bibr">41</xref>]</sup>. A recent clinical trial, the
Systolic Heart failure treatment with the If inhibitor ivabradine Trial (SHIFT),
showed the outcomes of patients with resting heart rates &#x02265;70 bpm were
significantly improved with the heart rate decreased<sup>[<xref rid="r42" ref-type="bibr">42</xref>]</sup>. A subgroup analysis of BEAUTIFUL trial
(morbidity-mortality evaluation of the If inhibitor ivabradine in patients with
coronary artery disease and left ventricular dysfunction study) suggested a specific
benefit for patients with heart rates over 70 bpm<sup>[<xref rid="r43" ref-type="bibr">43</xref>]</sup>, and echocardiography revealed that the reduction
in the left ventricular systolic volume index observed in the ivabradine treatment
was related to the degree of heart rate reduction, although the large study showed
the composite endpoint was not significantly different between the ivabradine and
the placebo groups. All of the results suggest that ivabradine improves cardiac
diseases outcome depends on its reduction of heart rates. In the treatment of
chronic heart failure, &#x003b2;-receptor blockers are used widely, but some
patients cannot tolerant &#x003b2;-receptor blockers (because
&#x003b2;-blockers may induce asthma, negative inotropic effect and so on), thus,
ivabradine maybe the alternative. Another study examined the effects of ivabradine
on survival and arrhythmicity in transgenic mice (dnNRSF-Tg). In this study,
ivabradine was used 7 mg/kg per day orally, and the results showed it significantly
reduced ventricular tachyarrhythmias and improved survival among dnNRSF-Tg mice
while having no significant effect on heart rate or cardiac structure or function.
Ivabradine inhibited the abnormal automaticity induced by &#x003b2;-adrenergic
stimulation and prevented the increase in automaticity in dnNRSF-Tg mice<sup>[<xref rid="r39" ref-type="bibr">39</xref>]</sup>. It is well known that the
incidence of sinoatrial node dysfunction increases with age and is accompanied by
atrial fibrillation (AF) and other tachyarrhythmia<sup>[<xref rid="r44" ref-type="bibr">44</xref>]</sup>. AF is one of the most common arrhythmias. It is
estimated that 84% of the patients with AF are over 65 years old, and the incidence
rate of AF doubles every 10 years, the incidence rate of AF is 10% in people over 85
years old. It can lead to congestive heart failure, thromboembolism, and
cerebrovascular accident. So the mortality rate of AF is very high<sup>[<xref rid="r45" ref-type="bibr">45</xref>,<xref rid="r46" ref-type="bibr">46</xref>]</sup>. Recent animal study showed that dogs with agerelated AF
induced by rapid atrial pacing administered ivabradine for intervention, and
ivabradine could increase the effective refractory periods in the left atrium and
left superior pulmonary vein, reduce the duration of AF after induction, and
significantly decrease the inducing rate of AF (the incidence rate of AF decreased
from 50% to 25%). Therefore, ivabradine has potential effects in preventing
age-related AF<sup>[<xref rid="r47" ref-type="bibr">47</xref>]</sup>. Amiodarone is
one of the most frequently used anti-arrhythmic drugs. Amiodarone was shown to
inhibit HCN channel currents in oocytes and HEK-cells. To determine the effects of
amiodarone under pathological conditions, a study monitored If under the amiodarone
treatment in ventricular myocytes from spontaneously hypertensive rats with left
ventricular hypertrophy using the whole-cell patch-clamp technique. The findings of
the study showed that the incubation of myocytes with amiodarone significantly
suppressed If density and downregulated HCN2 and HCN4 expression at both the mRNA
and protein level. This is the first study indicating that amiodarone inhibits If
under hypertrophied condition<sup>[<xref rid="r48" ref-type="bibr">48</xref>]</sup>.</p></sec><sec><title>PERSPECTIVES</title><p>With the development of the study on HCN channels, the importance of HCN channels on
heart diseases attracted more attention. The biological pacemaker based on HCN
channels has attached much attention, and a lot of <italic>in vitro</italic> and
<italic>in vivo</italic> gene transduction experiments proved the feasibility of
constructing cardiac biological pacemaker, but its clinical application and safety
issues is yet to be confirmed further. In order to avoid side effects of HCN channel
blockers, the subtype-selective HCN channel blocker is promising.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Zong</surname><given-names>X</given-names></name><name><surname>Jeglitsch</surname><given-names>M</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Biel</surname><given-names>M</given-names></name></person-group><article-title>A family of hyperpolarization-activated mammalian cation
channels</article-title><source>Nature</source><year>1998</year><volume>393</volume><issue>6685</issue><fpage>587</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">9634236</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>RB</given-names></name><name><surname>Siegelbaum</surname><given-names>SA</given-names></name></person-group><article-title>Hyperpolarization-activated cation currents: from molecules to
physiological function</article-title><source>Annu Rev Physiol</source><year>2003</year><volume>65</volume><fpage>453</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">12471170</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahl-Schott</surname><given-names>C</given-names></name><name><surname>Biel</surname><given-names>M</given-names></name></person-group><article-title>HCN channels: structure, cellular regulation and physiological
function</article-title><source>Cell Mol Life Sci</source><year>2009</year><volume>66</volume><issue>3</issue><fpage>470</fpage><lpage>494</lpage><pub-id pub-id-type="pmid">18953682</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiFrancesco</surname><given-names>D</given-names></name></person-group><article-title>The role of the funny current in pacemaker
activity</article-title><source>Circ Res</source><year>2010</year><volume>106</volume><issue>3</issue><fpage>434</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">20167941</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>HJ</given-names></name><name><surname>Furness</surname><given-names>JB</given-names></name><name><surname>Jennings</surname><given-names>EA</given-names></name></person-group><article-title>Postnatal maturation of the hyperpolarisation-activated cation
current, I(h), in trigeminal sensory neurons</article-title><source>J Neurophysiol</source><year>2011</year><volume>106</volume><issue>4</issue><fpage>2045</fpage><lpage>2056</lpage><pub-id pub-id-type="pmid">21753027</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>A</given-names></name></person-group><article-title>Age-related down-regulation of HCN channels in rat sinoatrial
node</article-title><source>Basic Res Cardiol</source><year>2007</year><volume>102</volume><issue>5</issue><fpage>429</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">17572839</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surges</surname><given-names>R</given-names></name><name><surname>Brewster</surname><given-names>AL</given-names></name><name><surname>Bender</surname><given-names>RA</given-names></name><name><surname>Beck</surname><given-names>H</given-names></name><name><surname>Feuerstein</surname><given-names>TJ</given-names></name><name><surname>Baram</surname><given-names>TZ</given-names></name></person-group><article-title>Regulated expression of HCN channels and cAMP levels shape the
properties of the h current in developing rat hippocampus</article-title><source>Eur J Neurosci</source><year>2006</year><volume>24</volume><issue>1</issue><fpage>94</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">16882011</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrmann</surname><given-names>S</given-names></name><name><surname>Layh</surname><given-names>B</given-names></name><name><surname>Ludwig</surname><given-names>A</given-names></name></person-group><article-title>Novel insights into the distribution of cardiac HCN channels: an
expression study in the mouse heart</article-title><source>J Mol Cell Cardiol</source><year>2011</year><volume>51</volume><issue>6</issue><fpage>997</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">21945247</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenske</surname><given-names>S</given-names></name><name><surname>Krause</surname><given-names>SC</given-names></name><name><surname>Hassan</surname><given-names>SI</given-names></name><name><surname>Becirovic</surname><given-names>E</given-names></name><name><surname>Auer</surname><given-names>F</given-names></name><name><surname>Bernard</surname><given-names>R</given-names></name><etal/></person-group><article-title>Sick sinus syndrome in HCN1-deficient mice</article-title><source>Circulation</source><year>2013</year><volume>128</volume><issue>24</issue><fpage>2585</fpage><lpage>2594</lpage><pub-id pub-id-type="pmid">24218458</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Zong</surname><given-names>X</given-names></name><name><surname>Jeglitsch</surname><given-names>M</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Biel</surname><given-names>M</given-names></name></person-group><article-title>A family of hyperpolarization-activated mammalian cation
channels</article-title><source>Nature</source><year>1998</year><volume>393</volume><issue>6685</issue><fpage>587</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">9634236</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrmann</surname><given-names>S</given-names></name><name><surname>Layh</surname><given-names>B</given-names></name><name><surname>Ludwig</surname><given-names>A</given-names></name></person-group><article-title>Novel insights into the distribution of cardiac HCN channels: an
expression study in the mouse heart</article-title><source>J Mol Cell Cardiol</source><year>2011</year><volume>51</volume><issue>6</issue><fpage>997</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">21945247</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenske</surname><given-names>S</given-names></name><name><surname>Mader</surname><given-names>R</given-names></name><name><surname>Scharr</surname><given-names>A</given-names></name><name><surname>Paparizos</surname><given-names>C</given-names></name><name><surname>Cao-Ehlker</surname><given-names>X</given-names></name><name><surname>Michalakis</surname><given-names>S</given-names></name><etal/></person-group><article-title>HCN3 contributes to the ventricular action potential waveform in
the murine heart</article-title><source>Circ Res</source><year>2011</year><volume>109</volume><issue>9</issue><fpage>1015</fpage><lpage>1023</lpage><pub-id pub-id-type="pmid">21903939</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasui</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Opthof</surname><given-names>T</given-names></name><name><surname>Kada</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>JK</given-names></name><name><surname>Kamiya</surname><given-names>K</given-names></name><etal/></person-group><article-title>I(f) current and spontaneous activity in mouse embryonic
ventricular myocytes</article-title><source>Circ Res</source><year>2001</year><volume>88</volume><issue>5</issue><fpage>536</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">11249878</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerbai</surname><given-names>E</given-names></name><name><surname>Pino</surname><given-names>R</given-names></name><name><surname>Sartiani</surname><given-names>L</given-names></name><name><surname>Mugelli</surname><given-names>A</given-names></name></person-group><article-title>Influence of postnataldevelopment on I(f) occurrence and
properties in neonatal rat ventricular myocytes</article-title><source>Cardiovasc Res</source><year>1999</year><volume>42</volume><issue>2</issue><fpage>416</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">10533577</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pian</surname><given-names>P</given-names></name><name><surname>Bucchi</surname><given-names>A</given-names></name><name><surname>Decostanzo</surname><given-names>A</given-names></name><name><surname>Robinson</surname><given-names>RB</given-names></name><name><surname>Siegelbaum</surname><given-names>SA</given-names></name></person-group><article-title>Modulation of cyclic nucleotide-regulated HCN channels by PIP(2)
and receptors coupled to phospholipase C</article-title><source>Pflugers Arch</source><year>2007</year><volume>455</volume><issue>1</issue><fpage>125</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">17605039</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloss</surname><given-names>B</given-names></name><name><surname>Trost</surname><given-names>S</given-names></name><name><surname>Bluhm</surname><given-names>W</given-names></name><name><surname>Swanson</surname><given-names>E</given-names></name><name><surname>Clark</surname><given-names>R</given-names></name><name><surname>Winkfein</surname><given-names>R</given-names></name><etal/></person-group><article-title>Cardiac ion channel expression and contractile function in mice
with deletion of thyroid hormone receptor alpha or beta</article-title><source>Endocrinology</source><year>2001</year><volume>142</volume><issue>2</issue><fpage>544</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">11159823</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pachucki</surname><given-names>J</given-names></name><name><surname>Burmeister</surname><given-names>LA</given-names></name><name><surname>Larsen</surname><given-names>PR</given-names></name></person-group><article-title>Thyroid hormone regulates hyperpolarization-activated cyclic
nucleotide-gated channel (HCN2) mRNA in the rat heart</article-title><source>Circ Res</source><year>1999</year><volume>85</volume><issue>6</issue><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">10488052</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stillitamo</surname><given-names>F</given-names></name><name><surname>Lonardo</surname><given-names>G</given-names></name><name><surname>Zicha</surname><given-names>S</given-names></name><name><surname>Varro</surname><given-names>A</given-names></name><name><surname>Cerbai</surname><given-names>E</given-names></name><name><surname>Mugelli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Molecular basis of funny current (If) in normal and failing human
heart</article-title><source>J Mol Cell Cardiol</source><year>2008</year><volume>45</volume><issue>2</issue><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">18556018</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Wymore</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Wymore</surname><given-names>RT</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Distribution and prevalence of hyperpolarization-activated cation
channel (HCN) mRNA expression in cardiac tissues</article-title><source>Circ Res</source><year>1999</year><volume>85</volume><issue>1</issue><fpage>e1</fpage><lpage>e6</lpage><pub-id pub-id-type="pmid">10400919</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marionneau</surname><given-names>C</given-names></name><name><surname>Couette</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Mangoni</surname><given-names>ME</given-names></name><name><surname>Nargeot</surname><given-names>J</given-names></name><etal/></person-group><article-title>Specific pattern of ionic channel gene expression associated with
pacemaker activity in the mouse heart</article-title><source>J Physiol</source><year>2005</year><volume>562</volume><issue>1</issue><fpage>223</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">15498808</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerbai</surname><given-names>E</given-names></name><name><surname>Sartiani</surname><given-names>L</given-names></name><name><surname>DePaoli</surname><given-names>P</given-names></name><name><surname>Pino</surname><given-names>R</given-names></name><name><surname>Maccherini</surname><given-names>M</given-names></name><name><surname>Bizzarri</surname><given-names>F</given-names></name><etal/></person-group><article-title>The properties of the pacemaker current I(F) in human ventricular
myocytes are modulated by cardiac disease</article-title><source>J Mol Cell Cardiol</source><year>2001</year><volume>33</volume><issue>3</issue><fpage>441</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">11181013</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sridhar</surname><given-names>A</given-names></name><name><surname>Dech</surname><given-names>SJ</given-names></name><name><surname>Lacombe</surname><given-names>VA</given-names></name><name><surname>Elton</surname><given-names>TS</given-names></name><name><surname>McCune</surname><given-names>SA</given-names></name><name><surname>Altschuld</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Abnormal diastolic currents in ventricular myocytes from
spontaneous hypertensive heart failure rats</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2006</year><volume>291</volume><issue>5</issue><fpage>H2192</fpage><lpage>H2198</lpage><pub-id pub-id-type="pmid">16766638</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerbai</surname><given-names>E</given-names></name><name><surname>Mugelli</surname><given-names>A</given-names></name></person-group><article-title>I(f) in non-pacemaker cells: role and pharmacological
implications</article-title><source>Pharmacol Res</source><year>2006</year><volume>53</volume><issue>5</issue><fpage>416</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">16713285</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerbai</surname><given-names>E</given-names></name><name><surname>Pino</surname><given-names>R</given-names></name><name><surname>Porciatti</surname><given-names>F</given-names></name><name><surname>Sani</surname><given-names>G</given-names></name><name><surname>Toscano</surname><given-names>M</given-names></name><name><surname>Maccherini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Characterization of the hyperpolarization-activated current, I(f
), in ventricular myocytes from human failing heart</article-title><source>Circulation</source><year>1997</year><volume>95</volume><issue>3</issue><fpage>568</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">9024140</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerbai</surname><given-names>E</given-names></name><name><surname>Barbieri</surname><given-names>M</given-names></name><name><surname>Mugelli</surname><given-names>A</given-names></name></person-group><article-title>Occurrence and properties of the hyperpolarization-activated
current If in ventricular myocytes from normotensive and hypertensive rats
during aging</article-title><source>Circulation</source><year>1996</year><volume>94</volume><issue>7</issue><fpage>1674</fpage><lpage>1681</lpage><pub-id pub-id-type="pmid">8840860</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stilli</surname><given-names>D</given-names></name><name><surname>Sgoifo</surname><given-names>A</given-names></name><name><surname>Macchi</surname><given-names>E</given-names></name><name><surname>Zaniboni</surname><given-names>M</given-names></name><name><surname>De Iasio</surname><given-names>S</given-names></name><name><surname>Cerbai</surname><given-names>E</given-names></name><etal/></person-group><article-title>Myocardial remodeling and arrhythmogenesis in moderate cardiac
hypertrophy in rats</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2001</year><volume>280</volume><issue>1</issue><fpage>H142</fpage><lpage>H150</lpage><pub-id pub-id-type="pmid">11123228</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppe</surname><given-names>UC</given-names></name><name><surname>Jansen</surname><given-names>E</given-names></name><name><surname>S&#x000fc;dkamp</surname><given-names>M</given-names></name><name><surname>Beuckelmann</surname><given-names>DJ</given-names></name></person-group><article-title>Hyperpolarizationactivated inward current in ventricular myocytes
from normal and failing human hearts</article-title><source>Circulation</source><year>1998</year><volume>97</volume><issue>1</issue><fpage>55</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">9443432</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michael</surname><given-names>G</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Qi</surname><given-names>XY</given-names></name><name><surname>Dobrev</surname><given-names>D</given-names></name><name><surname>Nattel</surname><given-names>S</given-names></name></person-group><article-title>Remodelling of cardiac repolarization: how homeostatic responses
can lead to arrhythmogenesis</article-title><source>Cardiovasc Res</source><year>2009</year><volume>81</volume><issue>3</issue><fpage>491</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">18826964</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>KL</given-names></name><name><surname>Jones</surname><given-names>NC</given-names></name><name><surname>Kennard</surname><given-names>JT</given-names></name><name><surname>Ng</surname><given-names>C</given-names></name><name><surname>Urmaliya</surname><given-names>V</given-names></name><name><surname>Lau</surname><given-names>S</given-names></name><etal/></person-group><article-title>HCN channelopathy and cardiac electrophysiologic dysfunction in
genetic and acquired rat epilepsy models</article-title><source>Epilepsia</source><year>2014</year><volume>55</volume><issue>4</issue><fpage>609</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">24592881</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenske</surname><given-names>S</given-names></name><name><surname>Krause</surname><given-names>SC</given-names></name><name><surname>Hassan</surname><given-names>SI</given-names></name><name><surname>Becirovic</surname><given-names>E</given-names></name><name><surname>Auer</surname><given-names>F</given-names></name><name><surname>Bernard</surname><given-names>R</given-names></name><etal/></person-group><article-title>Sick sinus syndrome in HCN1-deficient mice</article-title><source>Circulation</source><year>2013</year><volume>128</volume><issue>24</issue><fpage>2585</fpage><lpage>2594</lpage><pub-id pub-id-type="pmid">24218458</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brundel</surname><given-names>BJ</given-names></name><name><surname>Shiroshita-Takeshita</surname><given-names>A</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Yeh</surname><given-names>YH</given-names></name><name><surname>Chartier</surname><given-names>D</given-names></name><name><surname>van Gelder</surname><given-names>IC</given-names></name><etal/></person-group><article-title>Induction of heat shock response protects the heart against
atrial fibrillation</article-title><source>Circ Res</source><year>2006</year><volume>99</volume><issue>12</issue><fpage>1394</fpage><lpage>1402</lpage><pub-id pub-id-type="pmid">17110598</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>S</given-names></name><name><surname>Kuwahara</surname><given-names>T</given-names></name><name><surname>Kobori</surname><given-names>A</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Takei</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prevalence, electrophysiological properties, and clinical
implications of dissociated pulmonary vein activity following pulmonary vein
antrum isolation</article-title><source>Am J Cardiol</source><year>2011</year><volume>108</volume><issue>8</issue><fpage>1147</fpage><lpage>1154</lpage><pub-id pub-id-type="pmid">21791333</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Bary</surname><given-names>C</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Dornia</surname><given-names>C</given-names></name><name><surname>Eissnert</surname><given-names>C</given-names></name><name><surname>Fellner</surname><given-names>C</given-names></name><name><surname>Latzin</surname><given-names>P</given-names></name><etal/></person-group><article-title>Evaluation of pulmonary vein stenosis after pulmonary vein
isolation using a novel circular mapping and ablation catheter
(PVAC)</article-title><source>Circ Arrhythm Electrophysiol</source><year>2011</year><volume>4</volume><issue>5</issue><fpage>630</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">21841188</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>JR</given-names></name><name><surname>Cha</surname><given-names>TJ</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Chartier</surname><given-names>D</given-names></name><name><surname>Melnyk</surname><given-names>P</given-names></name><name><surname>Hohnloser</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Cellular electrophysiology of canine pulmonary vein
cardiomyocytes: action potential and ionic current
properties</article-title><source>J Physiol</source><year>2003</year><volume>551</volume><issue>3</issue><fpage>801</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">12847206</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Chen</surname><given-names>SA</given-names></name><name><surname>Chang</surname><given-names>MS</given-names></name><name><surname>Lin</surname><given-names>CI</given-names></name></person-group><article-title>Arrhythmogenic activity of cardiac muscle in pulmonary veins of
the dog: implication for the genesis of atrial fibrillation</article-title><source>Cardiovasc Res</source><year>2000</year><volume>48</volume><issue>2</issue><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">11054473</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nattel</surname><given-names>S</given-names></name><name><surname>Maguy</surname><given-names>A</given-names></name><name><surname>Le Bouter</surname><given-names>S</given-names></name><name><surname>Yeh</surname><given-names>YH</given-names></name></person-group><article-title>Arrhythmogenic ion-channel remodeling in the heart: heart
failure, myocardial infarction, and atrial fibrillation</article-title><source>Physiol Rev</source><year>2007</year><volume>87</volume><issue>2</issue><fpage>425</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">17429037</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marionneau</surname><given-names>C</given-names></name><name><surname>Brunet</surname><given-names>S</given-names></name><name><surname>Flagg</surname><given-names>TP</given-names></name><name><surname>Pilgram</surname><given-names>TK</given-names></name><name><surname>Demolombe</surname><given-names>S</given-names></name><name><surname>Nerbonne</surname><given-names>JM</given-names></name></person-group><article-title>Distinct cellular and molecular mechanisms underlie functional
remodeling of repolarizing K+ currents with left ventricular
hypertrophy</article-title><source>Circ Res</source><year>2008</year><volume>102</volume><issue>11</issue><fpage>1406</fpage><lpage>1415</lpage><pub-id pub-id-type="pmid">18451341</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plotnikov</surname><given-names>AN</given-names></name><name><surname>Bucchi</surname><given-names>A</given-names></name><name><surname>Shlapakova</surname><given-names>I</given-names></name><name><surname>Danilo</surname><given-names>P Jr</given-names></name><name><surname>Brink</surname><given-names>PR</given-names></name><name><surname>Robinson</surname><given-names>RB</given-names></name></person-group><article-title>HCN212-channel biological pacemakers manifesting ventricular
tachyarrhythmias are responsive to treatment with I(f)
blockade</article-title><source>Heart Rhythm</source><year>2008</year><volume>5</volume><issue>2</issue><fpage>282</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">18242555</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuwabara</surname><given-names>Y</given-names></name><name><surname>Kuwahara</surname><given-names>K</given-names></name><name><surname>Takano</surname><given-names>M</given-names></name><name><surname>Kinoshita</surname><given-names>H</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Yasuno</surname><given-names>S</given-names></name><etal/></person-group><article-title>Increased expression of HCN channels in the ventricular
myocardium contributes to enhanced arrhythmicity in mouse failing
hearts</article-title><source>J Am Heart Assoc</source><year>2013</year><volume>2</volume><issue>3</issue><elocation-id/></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JY</given-names></name><name><surname>Wang</surname><given-names>HJ</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>XP</given-names></name><name><surname>Fu</surname><given-names>YC</given-names></name><name><surname>Chen</surname><given-names>MY</given-names></name><etal/></person-group><article-title>Hyperpolarization activated cation current (I(f)) in cardiac
myocytes from pulmonary vein sleeves in the canine with atrial
fibrillation</article-title><source>J Geriatr Cardiol</source><year>2012</year><volume>9</volume><issue>4</issue><fpage>366</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">23335943</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riccioni</surname><given-names>G</given-names></name></person-group><article-title>Ivabradine: recent and potential applications in clinical
practice</article-title><source>Expert Opin Pharmacother</source><year>2011</year><volume>12</volume><issue>3</issue><fpage>443</fpage><lpage>450</lpage><pub-id pub-id-type="pmid">21254949</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Komajda</surname><given-names>M</given-names></name><name><surname>B&#x000f6;ehm</surname><given-names>M</given-names></name><name><surname>Borer</surname><given-names>JS</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Dubost-Brama</surname><given-names>A</given-names></name><etal/></person-group><article-title>Ivabradine and outcomes in chronic heart failure (SHIFT): a
randomised placebo-controlled study</article-title><source>Lancet</source><year>2010</year><volume>376</volume><issue>9744</issue><fpage>875</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">20801500</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>K</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Steg</surname><given-names>PG</given-names></name><name><surname>Tendera</surname><given-names>M</given-names></name><name><surname>Robertson</surname><given-names>M</given-names></name><name><surname>Ferrari</surname><given-names>R</given-names></name><collab>BEAUTIFUL investigators</collab></person-group><article-title>Heart rate as a prognostic risk factor in patients with coronary
artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a
subgroup analysis of a randomised controlled trial</article-title><source>Lancet</source><year>2008</year><volume>372</volume><issue>9641</issue><fpage>817</fpage><lpage>821</lpage><pub-id pub-id-type="pmid">18757091</pub-id></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semelka</surname><given-names>M</given-names></name><name><surname>Gera</surname><given-names>J</given-names></name><name><surname>Usman</surname><given-names>S</given-names></name></person-group><article-title>Sick sinus syndrome: a review</article-title><source>Am Fam Physician</source><year>2013</year><volume>87</volume><issue>10</issue><fpage>691</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">23939447</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chimenti</surname><given-names>C</given-names></name><name><surname>Russo</surname><given-names>MA</given-names></name><name><surname>Carpi</surname><given-names>A</given-names></name><name><surname>Frustaci</surname><given-names>A</given-names></name></person-group><article-title>Histological substrate of human atrial
fibrillation</article-title><source>Biomed Pharmacother</source><year>2010</year><volume>64</volume><issue>3</issue><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">20006465</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccini</surname><given-names>JP</given-names></name><name><surname>Hammill</surname><given-names>BG</given-names></name><name><surname>Sinner</surname><given-names>MF</given-names></name><name><surname>Jensen</surname><given-names>PN</given-names></name><name><surname>Hernandez</surname><given-names>AF</given-names></name><name><surname>Heckbert</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Incidence and prevalence of atrial fibrillation and associated
mortality among Medicare beneficiaries, 1993-2007</article-title><source>Circ Cardiovasc Qual Outcomes</source><year>2012</year><volume>5</volume><issue>1</issue><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">22235070</pub-id></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YD</given-names></name><name><surname>Ji</surname><given-names>YT</given-names></name><name><surname>Zhou</surname><given-names>XH</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Hong</surname><given-names>YF</given-names></name><name><surname>Li</surname><given-names>JX</given-names></name><etal/></person-group><article-title>Effects of ivabradine on cardiac electrophysiology in dogs with
aged-related atrial fibrillation</article-title><source>Med Sci Monit</source><year>2015</year><volume>21</volume><fpage>1414</fpage><lpage>1420</lpage><pub-id pub-id-type="pmid">25982136</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Dual effects of amiodarone on pacemaker currents in hypertrophied
ventricular myocytes isolated from spontaneously hypertensive
rats</article-title><source>Clin Exp Pharmacol Physiol</source><year>2014</year><volume>41</volume><issue>9</issue><fpage>698</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">24862298</pub-id></element-citation></ref></ref-list></back></article>